Abstract
Malaysia is a small country with a diverse ethnic composition. The potential of the domestic pharmaceutical industry has been recognised by the Malaysian government, which views it as a strategic industry. This chapter gives a brief overview of the pharmaceutical industry and the market in Malaysia. It further discusses the healthcare system and the prevailing pharmaceutical regulations in the country. It goes on to describe clinical trials undertaken and registered in Malaysia and outlines the challenges and opportunities of doing clinical trials in the country.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
